VRON-0300

N/A

Report date: 2023/11/17 17:41:00

Base Information

Drug NameVRON-0300
Drug Alias NameVRON-0300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCheckpoint kinase modulatorsImmunostimulantsT lymphocytes stimulants
TargetsCheckpoint kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirion Therapeutics LLCOcean Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesVirion Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A